Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
No, I don’t think we can take a pill (s) to completely avoid Alzheimer’s Disease (AD). But I do think we can enhance our brain health and reduce our risk of dementia as we age through:
The devil is in the details as the saying goes. This post focuses on the first two categories above.
Let me take a step back. My diagnosis of a blood cancer called multiple myeloma in early 1994 led to aggressive chemotherapy and radiation and a long-term side effect called chemotherapy-induced cognitive dysfunction aka chemobrain.
Once I figured out what was wrong with my thinking, I spent years researching therapies shown to enhance brain health. As I worked through my fifties and rounded 60 years of age, I decided that I should add the study of dementia to my chemobrain research.
As you can imagine, many/most symptoms overlap. In short, it is all about enhancing brain health. On that note, as far as I can tell
all have a great deal in common.
The bottom line is that I work daily to improve my brain health. If you have any questions about your own brain health scroll down the page, post a question or a comment and I will reply to you ASAP.
Thanks,
Recommended Reading:
“Higher levels of specific carotenoid antioxidants in blood may help guard against age-related dementia, new research suggests.
Investigators found that individuals with the highest serum levels of lutein+zeaxanthin and beta-cryptoxanthin at baseline were less likely to have dementia decades later than their peers with lower levels of these antioxidants.
Lutein and zeaxanthin are found in green leafy vegetables such as kale, spinach, broccoli and peas. Beta-cryptoxanthin is found in fruits such as oranges, papaya, tangerines, and persimmons.
“Antioxidants may help protect the brain from oxidative stress, which can cause cell damage…”
“Experts do not yet know the daily level of antioxidant intake to promote healthy aging of the brain. More research is needed to establish the necessary level of antioxidant intake — through the diet and/or supplements — to promote brain health and healthy aging,” he added…
They add that the study contributes to the belief that antioxidants don’t act independently of each other or other factors, including socioeconomic status and lifestyle, in the mediation of dementia risk...
“A new study from AlMaarefa University in Saudi Arabia indicates that vitamin K may help protect against “cognitive deterioration.” The new study, which was presented at the Experimental Biology meeting on April 5th, 2022, tested giving a vitamin K supplement to rats…
Since vitamin K can affect brain functioning, the researchers in this study wanted to see how it affects cognitive functioning in rats.
The researchers conducted a 17-month long trial on rats. One group received a vitamin K supplement, and the other did not.
The researchers administered Menaquinone-7 (MK-7), which the authors note “is a major form of vitamin K2.”
The rats went through a series of cognitive functioning tests throughout the study. According to the authors, they tested “to assess cognitive level, anxious, and depressive-like behavior.”
By the end of the study, the rats that received the vitamin K supplements had reduced levels of cognitive impairment, depression, and anxiety. Additionally, the authors note that these rats experienced “improved spatial memory and learning ability.”
“Vitamin K2 demonstrated a very promising impact in hindering aging-related behavioral, functional, biochemical, and histopathological changes in the senile aging brain,” says Prof. El-Sherbiny.
“Objectives- To examine the prospective relation between total and 6 classes of dietary flavonoid intake and risk of ADRD and Alzheimer disease (AD) while addressing limitations of earlier observational studies.
Our findings imply that higher long-term dietary intakes of flavonoids are associated with lower risks of ADRD and AD in US adults…”